Clinical Trials Core

临床试验核心

• 批准号: 8664641
• 负责人: Robert Keith
• 金额: $ 26.18万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8664641
• 关键词: American College of Radiology Imaging Network; Basic Science; Bioinformatics; Biological; Biological Markers; Biopsy; Cancer Center; Cancer Patient; Chemoprevention; Clinic; Clinical; Clinical Data; Clinical Research Associate; Clinical Trials; Clinical Trials Design; Collaborations; Collection; Colorado; Companions; Consent; Correlative Study; Cytology; Data; Databases; Detection; Development; Diagnostic; Diagnostic tests; Early Diagnosis; Electronics; Enrollment; Epidemiology; Evaluation; Exhalation; Funding; Future; Gene Mutation; Genes; Goals; Grant; Hand; Hospitals; Human; Human Resources; Individual; Industry; Internet; Investigation; Laboratories; Laboratory Finding; Link; Lung; Malignant Neoplasms; Malignant neoplasm of lung; Maps; Methylation; Molecular; Monitor; Nature; Pathway interactions; Patients; Phase; Play; Preparation; Prevention; Prevention strategy; Principal Investigator; Procedures; Process; Protocols documentation; Publications; Reporting; Research Design; Research Infrastructure; Research Personnel; Resources; Retrieval; Risk; Role; Safety; Sampling; Science; Scientist; Site; Southwest Oncology Group; Specimen; Study Subject; System; Therapeutic; Therapeutic Intervention; Therapy Clinical Trials; Tissue Banking; Tissue Banks; Tissue Sample; Tissues; Training; Translating; Translational Research; Translations; Tyrosine Kinase Inhibitor; Visit; Work; base; biobank; cancer risk; clinical application; database design; design; electronic data; high risk; human subject; human tissue; innovation; lung carcinogenesis; novel; novel strategies; programs; promoter; relational database; resistance mechanism; screening; statistics; tissue/cell culture; tool; translational approach

The goal of the Clinical Trials Core (CTC) is to provide support for clinical trials designed and implemented for SPORE projects. The support includes assistance with trial preparation, regulatory issues, data safety and monitoring, auditing, conduct, and reporting. Our increasing understanding of the molecular basis of lung cancer has reinforced the need to continue conducting studies which involve the collection of both clinical data and specimens for molecular analyses. This translational approach allows for the investigation of biological pathways of lung carcinogenesis in human tissue, and acts as a powerful tool in the evaluation of novel strategies for the prevention, screening, early detection, and treatment of lung cancer. The CTC has been essential in translating the science generated from each of the individual projects. The CTC has played a crucial role in the Colorado SPORE due the nature of our trials. Our trials have largely focused on chemoprevention, early detection, and tissue acquisition, and have robust enrollments and specimens. Trial subjects are predominantly enrolled from pulmonary clinics at affiliated Hospitals where Cancer Center personnel are not located. These are high risk subjects who do not yet have lung cancer. In addition, specialized training is required for the collection and handling of large numbers of specimens from each procedure at each visit. Special processing to allow separation of diagnostic tissue from remnant tissue and for cell culture is required. The Clinical Trials Core utilizes two databases. The SPORE Bioinformatics core provides a biorepository database that manages the storage and retrieval of biospecimens related to SPORE trials. This database also tracks all SPORE study subjects, enrollments, and personnel providing key statistics for grant reporting. The NCl¿s Center for Bioinformatics provided our remote data capture management system in Oracle Clinical, and this provides a full suite of capabilities to facilitate study design, data entry, replication, and discrepancy management. We have a team of clinical research associates expertly trained to accrue subjects and collect data/tissue samples for all SPORE-supported trials. All data is entered into a web database designed to link the clinical information to the biological correlative studies for future analyses. During the previous five year funding period there have been 9 trials supported by the Clinical Trials Core and these trials have enrolled 720 subjects. Additional trials are being actively planned based on basic science and clinical discoveries. The CTC support has led to 34 publications involving all of the projects and to multiple vertical collaborations and subsequent trials

临床试验核心（CTC）的目标是为《孢子》项目设计和实施的临床试验提供支持。支持包括协助试验准备、监管问题、数据安全和监测、审计、行为和报告。我们对肺癌分子基础的日益了解，加强了继续开展涉及临床数据和分子分析标本收集的研究的必要性。这种转化方法允许研究人体组织中肺癌发生的生物学途径，并作为评估肺癌预防、筛查、早期发现和治疗新策略的有力工具。CTC在翻译每个单独项目产生的科学成果方面发挥了至关重要的作用。